Source: International Congress 2018 – Biomarkers for evaluating COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Thornadtsson (Gävle, Sweden), A. Malinovschi (Uppsala, Sweden), K. BröMs (Gävle, Sweden), K. Lisspers (Uppsala, Sweden), B. StäLlberg (Uppsala, Sweden), C. Janson (Uppsala, Sweden), M. HöGman (Uppsala, Sweden). Clinical correlates of alveolar nitric oxide in COPD. 1078

Member's Comments

No comment yet.

Related content which might interest you: Alveolar nitric oxide is increased in uncontrolled asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Partitioning of alveolar and conducting airway nitric oxide in asthma of different severity Source: Eur Respir J 2004; 24: Suppl. 48, 328s Year: 2004 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Hyperinflation is associated with reduced nitric oxide production in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 226s Year: 2005 Increased bronchial but not alveolar exhaled nitric oxide is associated with snoring Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019 Measurement of alveolar nitric oxide in patients with lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Nasal nitric oxide Source: Eur Respir Monogr 2010; 49: 71-81 Year: 2010 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Increased nitric oxide production by neutrophils in bronchial asthma Source: Eur Respir J 2001; 17: 868-871 Year: 2001 Clinical utility of fractional exhaled nitric oxide in severe asthma management Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019 Year: 2020 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Association between nitric oxide and clinical phenotype in children with CF Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008